Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ArQule begins phase I trial of ARQ-736 in advanced solid tumors

Dec. 9, 2010

ACT Biotech describes unique mechanism of action of ACTB-1003

Dec. 9, 2010

BI-6727 shows promise in phase I/II trial in acute myeloid leukemia

Dec. 9, 2010

Phase I/II data presented on MLN-8237 in hematological malignancies

Dec. 9, 2010

FDA advisory committee votes on sNDA for Avodart in prostate cancer

Dec. 9, 2010

Pfizer plans 2011 regulatory submissions for bosutinib in CML

Dec. 7, 2010

BioMarin receives U.K. approval for clinical trial of BMN-673 in genetically defined cancers

Dec. 7, 2010

Geron begins phase II imetelstat trial in breast cancer

Dec. 7, 2010

Agios Pharmaceuticals describes novel pyruvate kinase M2 activators

Dec. 7, 2010

Cell Therapeutics appeals FDA decision on pixantrone NDA for non-Hodgkin's lymphoma

Dec. 7, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...